Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$72.45 - $91.58 $289 - $366
-4 Closed
0 $0
Q4 2023

Feb 07, 2024

BUY
$80.59 - $92.61 $322 - $370
4 New
4 $0
Q3 2023

Oct 30, 2023

BUY
$82.56 - $93.49 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023

BUY
$82.56 - $93.49 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023

BUY
$80.84 - $89.45 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023

BUY
$73.85 - $86.14 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022

BUY
$63.3 - $78.66 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022

BUY
$49.27 - $66.08 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022

BUY
$43.77 - $63.22 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022

BUY
$49.55 - $74.59 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021

BUY
$57.6 - $70.59 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021

BUY
$51.81 - $118.56 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$111.01 - $139.48 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$88.75 - $119.95 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $2,950 - $3,649
-39 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$84.96 - $118.91 $254 - $356
-3 Reduced 7.14%
39 $3,000
Q1 2020

May 13, 2020

SELL
$74.34 - $121.82 $9,366 - $15,349
-126 Reduced 75.0%
42 $4,000
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $1,944 - $2,200
17 Added 11.26%
168 $19,000
Q3 2019

Nov 13, 2019

BUY
$117.16 - $138.52 $17,691 - $20,916
151 New
151 $19,000
Q2 2019

Aug 13, 2019

BUY
$81.74 - $120.34 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$89.96 - $114.58 $0 - $0
0 New
0 $0

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.